A. Adam

464 total citations
9 papers, 256 citations indexed

About

A. Adam is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, A. Adam has authored 9 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Ophthalmology, 4 papers in Molecular Biology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in A. Adam's work include Retinal Diseases and Treatments (5 papers), Glaucoma and retinal disorders (4 papers) and Retinal and Optic Conditions (2 papers). A. Adam is often cited by papers focused on Retinal Diseases and Treatments (5 papers), Glaucoma and retinal disorders (4 papers) and Retinal and Optic Conditions (2 papers). A. Adam collaborates with scholars based in Germany, Japan and Austria. A. Adam's co-authors include Kei Shinoda, Olcay Tatar, Salvatore Grisanti, C Eckardt, Karl Ulrich Bartz‐Schmidt, E. Kaiserling, Peter Ruck, Peter Stalmans, Matthias Lüke and Klaus Lücke and has published in prestigious journals such as American Journal of Ophthalmology, British Journal of Ophthalmology and Experimental Eye Research.

In The Last Decade

A. Adam

9 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Adam Germany 7 141 75 66 42 36 9 256
Sacha Nahon‐Estève France 11 156 1.1× 24 0.3× 64 1.0× 2 0.0× 20 0.6× 35 240
Tomomi Aoi Japan 7 83 0.6× 61 0.8× 73 1.1× 3 0.1× 19 0.5× 10 228
D. T. H. Tan Singapore 7 148 1.0× 275 3.7× 61 0.9× 2 0.0× 12 0.3× 10 326
BE DAMATO United Kingdom 8 224 1.6× 103 1.4× 87 1.3× 28 0.8× 20 359
Mohammed Rigi United States 7 119 0.8× 86 1.1× 80 1.2× 1 0.0× 25 0.7× 15 271
Elina Rantala Finland 8 223 1.6× 48 0.6× 81 1.2× 1 0.0× 50 1.4× 12 304
Luiz Fernando Teixeira Brazil 7 254 1.8× 75 1.0× 63 1.0× 1 0.0× 14 0.4× 16 291
Mary G. Mehaffey United States 9 274 1.9× 167 2.2× 135 2.0× 2 0.0× 5 0.1× 10 354
Aaron S. Gold United States 9 252 1.8× 121 1.6× 71 1.1× 20 0.6× 43 320
Juan D. Arias Colombia 7 211 1.5× 112 1.5× 32 0.5× 33 0.9× 21 256

Countries citing papers authored by A. Adam

Since Specialization
Citations

This map shows the geographic impact of A. Adam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Adam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Adam more than expected).

Fields of papers citing papers by A. Adam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Adam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Adam. The network helps show where A. Adam may publish in the future.

Co-authorship network of co-authors of A. Adam

This figure shows the co-authorship network connecting the top 25 collaborators of A. Adam. A scholar is included among the top collaborators of A. Adam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Adam. A. Adam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Scheble, Veit, Petra M. Bareiss, Anna Fischer, et al.. (2013). SOX2 Expression and Prognostic Significance in Ovarian Carcinoma. International Journal of Gynecological Pathology. 32(4). 358–367. 32 indexed citations
2.
Tatar, Olcay, A. Adam, Kei Shinoda, et al.. (2007). INFLUENCE OF VERTEPORFIN PHOTODYNAMIC THERAPY ON INFLAMMATION IN HUMAN CHOROIDAL NEOVASCULAR MEMBRANES SECONDARY TO AGE-RELATED MACULAR DEGENERATION. Retina. 27(6). 713–723. 28 indexed citations
3.
Tatar, Olcay, Kei Shinoda, A. Adam, et al.. (2006). Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes. British Journal of Ophthalmology. 91(2). 166–173. 28 indexed citations
4.
Tatar, Olcay, A. Adam, Kei Shinoda, et al.. (2006). Expression of VEGF and PEDF in Choroidal Neovascular Membranes Following Verteporfin Photodynamic Therapy. American Journal of Ophthalmology. 142(1). 95–104.e1. 83 indexed citations
5.
Tatar, Olcay, Kei Shinoda, A. Adam, et al.. (2006). Expression of endostatin in human choroidal neovascular membranes secondary to age-related macular degeneration. Experimental Eye Research. 83(2). 329–338. 14 indexed citations
6.
Tatar, Olcay, A. Adam, Michael Völker, et al.. (2006). Immunohistopathologic Evaluation of Choroidal Neovascular Membranes Following Intravitreal Bevacizumab (Avastin®) Therapy. 47(13). 864–864. 1 indexed citations
8.
Adam, A., et al.. (1999). The painful, protruding eye. Unilateral euthyroid Graves' ophthalmopathy.. PubMed. 105(7). 81–4. 2 indexed citations
9.
Xiao, Jiaqi, A. Adam, Peter Ruck, & E. Kaiserling. (1996). A Comparison of Methods for Heat-Mediated Antigen Retrieval for Immunoelectron Microscopy: Demonstration of Cytokeratin No. 18 in Normal and Neoplastic Hepatocytes. Biotechnic & Histochemistry. 71(6). 278–285. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026